CLINICAL_TRIALS
trial_result
· 2025-12-22
Clinical Trial Update: Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) [Phase 3]
Summary
Phase 3 trial results for dupilumab in allergic fungal rhinosinusitis have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Allergic Fungal Rhinosinusitis | Phase 3 | Status: COMPLETED | Results posted: 2025-12-22